BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36031103)

  • 1. Essential oil of Ligusticum chuanxiong Hort. Regulated P-gp protein and tight junction protein to change pharmacokinetic parameters of temozolomide in blood, brain and tumor.
    Shuai SY; Liu SS; Liu XJ; Zhang GS; Zheng Q; Yue PF; Yang M; Hu PY
    J Ethnopharmacol; 2022 Nov; 298():115646. PubMed ID: 36031103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the synergic mechanism of Ligusticum striatum DC. and borneol in attenuating BMECs injury and maintaining tight junctions against cerebral ischaemia based on the HIF-1α/VEGF signalling pathway.
    Song X; Xing W; Zhang X; Wang X; Ji J; Lu J; Yu B; Ruan M
    J Ethnopharmacol; 2023 Jan; 301():115764. PubMed ID: 36183951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Krüppel-like factor 4 regulates blood-tumor barrier permeability via ZO-1, occludin and claudin-5.
    Ma J; Wang P; Liu Y; Zhao L; Li Z; Xue Y
    J Cell Physiol; 2014 Jul; 229(7):916-26. PubMed ID: 24318462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-18a increased the permeability of BTB via RUNX1 mediated down-regulation of ZO-1, occludin and claudin-5.
    Miao YS; Zhao YY; Zhao LN; Wang P; Liu YH; Ma J; Xue YX
    Cell Signal; 2015 Jan; 27(1):156-67. PubMed ID: 25452107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roundabout 4 regulates blood-tumor barrier permeability through the modulation of ZO-1, Occludin, and Claudin-5 expression.
    Cai H; Liu W; Xue Y; Shang X; Liu J; Li Z; Wang P; Liu L; Hu Y; Liu Y
    J Neuropathol Exp Neurol; 2015 Jan; 74(1):25-37. PubMed ID: 25470344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the chemical composition, acute toxicity and skin sensitivity of essential oil from rhizomes of Ligusticum chuanxiong.
    Zhang H; Han T; Yu CH; Jiang YP; Peng C; Ran X; Qin LP
    J Ethnopharmacol; 2012 Dec; 144(3):791-6. PubMed ID: 23085396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of piR-DQ590027/MIR17HG regulating the permeability of glioma conditioned normal BBB.
    Leng X; Ma J; Liu Y; Shen S; Yu H; Zheng J; Liu X; Liu L; Chen J; Zhao L; Ruan X; Xue Y
    J Exp Clin Cancer Res; 2018 Oct; 37(1):246. PubMed ID: 30305135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Asarone promotes Temozolomide's entry into glioma cells and decreases the expression of P-glycoprotein and MDR1.
    Wang N; Zhang Q; Ning B; Luo L; Fang Y
    Biomed Pharmacother; 2017 Jun; 90():368-374. PubMed ID: 28380412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insight of "Yin-Jing" medical property ofLigusticum chuanxiong Hort. via pharmacokinetics and tissue distributions by ultra-performance liquid chromatography-triple quadrupole mass spectrometry.
    Yu X; Chai JH; Kong XW; Bai CX; Liang J; Kuang HX; Xia YG
    J Ethnopharmacol; 2023 Oct; 314():116569. PubMed ID: 37172919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA NEAT1 regulates permeability of the blood-tumor barrier via miR-181d-5p-mediated expression changes in ZO-1, occludin, and claudin-5.
    Guo J; Cai H; Zheng J; Liu X; Liu Y; Ma J; Que Z; Gong W; Gao Y; Tao W; Xue Y
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2240-2254. PubMed ID: 28185956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Borneol increases blood-tumour barrier permeability by regulating the expression levels of tight junction-associated proteins.
    Duan M; Xing Y; Guo J; Chen H; Zhang R
    Pharm Biol; 2016 Dec; 54(12):3009-3018. PubMed ID: 27431008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long noncoding RNA TUG1 regulates blood-tumor barrier permeability by targeting miR-144.
    Cai H; Xue Y; Wang P; Wang Z; Li Z; Hu Y; Li Z; Shang X; Liu Y
    Oncotarget; 2015 Aug; 6(23):19759-79. PubMed ID: 26078353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
    Liu LB; Xue YX; Liu YH; Wang YB
    J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of erythropoietin on blood-brain barrier tight junctions in ischemia-reperfusion rats.
    Liu K; Sun T; Wang P; Liu YH; Zhang LW; Xue YX
    J Mol Neurosci; 2013 Feb; 49(2):369-79. PubMed ID: 23001813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of miR-18a negatively regulates myocyte enhancer factor 2D to increase the permeability of the blood-tumor barrier via Krüppel-like factor 4-mediated downregulation of zonula occluden-1, claudin-5, and occludin.
    Zhao YY; Zhao LN; Wang P; Miao YS; Liu YH; Wang ZH; Ma J; Li Z; Li ZQ; Xue YX
    J Neurosci Res; 2015 Dec; 93(12):1891-902. PubMed ID: 26356851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential oil from rhizomes of Ligusticum chuanxiong induces apoptosis in hypertrophic scar fibroblasts.
    Wu JG; Ma L; Zhang SY; Zhu ZZ; Zhang H; Qin LP; Wei YJ
    Pharm Biol; 2011 Jan; 49(1):86-93. PubMed ID: 20815693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential oil from Ligusticum chuanxiong Hort. Alleviates lipopolysaccharide-induced neuroinflammation: Integrating network pharmacology and molecular mechanism evaluation.
    Zuo J; Zhang TH; Peng C; Xu BJ; Dai O; Lu Y; Zhou QM; Xiong L
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117337. PubMed ID: 37866462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics, tissue distribution and metabolism of senkyunolide I, a major bioactive component in Ligusticum chuanxiong Hort. (Umbelliferae).
    He CY; Wang S; Feng Y; Liang S; Lin X; Xu DS; Ruan KF
    J Ethnopharmacol; 2012 Aug; 142(3):706-13. PubMed ID: 22668502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of an accelerated solvent extraction dispersive liquid-liquid microextraction method for the separation and determination of essential oil from Ligusticum chuanxiong Hort by gas chromatography with mass spectrometry.
    Yang G; Sun Q; Hu Z; Liu H; Zhou T; Fan G
    J Sep Sci; 2015 Oct; 38(20):3588-98. PubMed ID: 26304788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic comparative study of gastrodin after oral administration of Gastrodia elata Bl. extract and its compatibility with the different indigents of Ligusticum chuanxiong Hort. to rats.
    Hu PY; Yue PF; Zheng Q; Yang M; Zhang GS; Wu B; Liu D
    J Ethnopharmacol; 2016 Sep; 191():82-86. PubMed ID: 27267828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.